Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells

Oriana Lo Re, Julien Douet, Marcus Buschbeck, Caterina Fusilli, Valerio Pazienza, Concetta Panebianco, Carlo Castruccio Castracani, Tommaso Mazza, Giovanni Li Volti, Manlio Vinciguerra

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are responsible for tumor relapse, metastasis, and chemoresistance. We recently showed that loss of macroH2A1, a variant of the histone H2A and an epigenetic regulator of stem-cell function, in HCC leads to CSC-like features such as resistance to chemotherapeutic agents and growth of large and relatively undifferentiated tumors in xenograft models. These HCC cells silenced for macroH2A1 also exhibited stem-like metabolic changes consistent with enhanced glycolysis. However, there is no consensus as to the metabolic characteristics of CSCs that render them adaptable to microenvironmental changes by conveniently shifting energy production source or by acquiring intermediate metabolic phenotypes. Here, we assessed long-term proliferation, energy metabolism, and central carbon metabolism in human hepatoma HepG2 cells depleted in macroH2A1. MacroH2A1-depleted HepG2 cells were insensitive to serum exhaustion and showed two distinct, but interdependent changes in glucose and lipid metabolism in CSCs: (1) massive upregulation of acetyl-coA that is transformed into enhanced lipid content and (2) increased activation of the pentose phosphate pathway, diverting glycolytic intermediates to provide precursors for nucleotide synthesis. Integration of metabolomic analyses with RNA-Seq data revealed a critical role for the Liver X Receptor pathway, whose inhibition resulted in attenuated CSCs-like features. These findings shed light on the metabolic phenotype of epigenetically modified CSC-like hepatic cells, and highlight a potential approach for selective therapeutic targeting.

Original languageEnglish
Pages (from-to)829-845
Number of pages17
JournalEpigenetics
Volume13
Issue number8
DOIs
Publication statusPublished - Aug 3 2018

Fingerprint

Neoplastic Stem Cells
Carbohydrate Metabolism
Lipid Metabolism
Histones
Hepatocellular Carcinoma
Hep G2 Cells
Phenotype
Pentose Phosphate Pathway
Metabolomics
Glycolysis
Heterografts
Epigenomics
Energy Metabolism
Hepatocytes
Neoplasms
Up-Regulation
Stem Cells
Carbon
Nucleotides
RNA

Keywords

  • cancer stem cells
  • hepatocellular carcinoma
  • Histone variants

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells. / Lo Re, Oriana; Douet, Julien; Buschbeck, Marcus; Fusilli, Caterina; Pazienza, Valerio; Panebianco, Concetta; Castracani, Carlo Castruccio; Mazza, Tommaso; Li Volti, Giovanni; Vinciguerra, Manlio.

In: Epigenetics, Vol. 13, No. 8, 03.08.2018, p. 829-845.

Research output: Contribution to journalArticle

Lo Re, Oriana ; Douet, Julien ; Buschbeck, Marcus ; Fusilli, Caterina ; Pazienza, Valerio ; Panebianco, Concetta ; Castracani, Carlo Castruccio ; Mazza, Tommaso ; Li Volti, Giovanni ; Vinciguerra, Manlio. / Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells. In: Epigenetics. 2018 ; Vol. 13, No. 8. pp. 829-845.
@article{a92a141dcd2645c595771e0a775cd4d9,
title = "Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells",
abstract = "Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are responsible for tumor relapse, metastasis, and chemoresistance. We recently showed that loss of macroH2A1, a variant of the histone H2A and an epigenetic regulator of stem-cell function, in HCC leads to CSC-like features such as resistance to chemotherapeutic agents and growth of large and relatively undifferentiated tumors in xenograft models. These HCC cells silenced for macroH2A1 also exhibited stem-like metabolic changes consistent with enhanced glycolysis. However, there is no consensus as to the metabolic characteristics of CSCs that render them adaptable to microenvironmental changes by conveniently shifting energy production source or by acquiring intermediate metabolic phenotypes. Here, we assessed long-term proliferation, energy metabolism, and central carbon metabolism in human hepatoma HepG2 cells depleted in macroH2A1. MacroH2A1-depleted HepG2 cells were insensitive to serum exhaustion and showed two distinct, but interdependent changes in glucose and lipid metabolism in CSCs: (1) massive upregulation of acetyl-coA that is transformed into enhanced lipid content and (2) increased activation of the pentose phosphate pathway, diverting glycolytic intermediates to provide precursors for nucleotide synthesis. Integration of metabolomic analyses with RNA-Seq data revealed a critical role for the Liver X Receptor pathway, whose inhibition resulted in attenuated CSCs-like features. These findings shed light on the metabolic phenotype of epigenetically modified CSC-like hepatic cells, and highlight a potential approach for selective therapeutic targeting.",
keywords = "cancer stem cells, hepatocellular carcinoma, Histone variants",
author = "{Lo Re}, Oriana and Julien Douet and Marcus Buschbeck and Caterina Fusilli and Valerio Pazienza and Concetta Panebianco and Castracani, {Carlo Castruccio} and Tommaso Mazza and {Li Volti}, Giovanni and Manlio Vinciguerra",
year = "2018",
month = "8",
day = "3",
doi = "10.1080/15592294.2018.1514239",
language = "English",
volume = "13",
pages = "829--845",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Taylor and Francis Inc.",
number = "8",

}

TY - JOUR

T1 - Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells

AU - Lo Re, Oriana

AU - Douet, Julien

AU - Buschbeck, Marcus

AU - Fusilli, Caterina

AU - Pazienza, Valerio

AU - Panebianco, Concetta

AU - Castracani, Carlo Castruccio

AU - Mazza, Tommaso

AU - Li Volti, Giovanni

AU - Vinciguerra, Manlio

PY - 2018/8/3

Y1 - 2018/8/3

N2 - Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are responsible for tumor relapse, metastasis, and chemoresistance. We recently showed that loss of macroH2A1, a variant of the histone H2A and an epigenetic regulator of stem-cell function, in HCC leads to CSC-like features such as resistance to chemotherapeutic agents and growth of large and relatively undifferentiated tumors in xenograft models. These HCC cells silenced for macroH2A1 also exhibited stem-like metabolic changes consistent with enhanced glycolysis. However, there is no consensus as to the metabolic characteristics of CSCs that render them adaptable to microenvironmental changes by conveniently shifting energy production source or by acquiring intermediate metabolic phenotypes. Here, we assessed long-term proliferation, energy metabolism, and central carbon metabolism in human hepatoma HepG2 cells depleted in macroH2A1. MacroH2A1-depleted HepG2 cells were insensitive to serum exhaustion and showed two distinct, but interdependent changes in glucose and lipid metabolism in CSCs: (1) massive upregulation of acetyl-coA that is transformed into enhanced lipid content and (2) increased activation of the pentose phosphate pathway, diverting glycolytic intermediates to provide precursors for nucleotide synthesis. Integration of metabolomic analyses with RNA-Seq data revealed a critical role for the Liver X Receptor pathway, whose inhibition resulted in attenuated CSCs-like features. These findings shed light on the metabolic phenotype of epigenetically modified CSC-like hepatic cells, and highlight a potential approach for selective therapeutic targeting.

AB - Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are responsible for tumor relapse, metastasis, and chemoresistance. We recently showed that loss of macroH2A1, a variant of the histone H2A and an epigenetic regulator of stem-cell function, in HCC leads to CSC-like features such as resistance to chemotherapeutic agents and growth of large and relatively undifferentiated tumors in xenograft models. These HCC cells silenced for macroH2A1 also exhibited stem-like metabolic changes consistent with enhanced glycolysis. However, there is no consensus as to the metabolic characteristics of CSCs that render them adaptable to microenvironmental changes by conveniently shifting energy production source or by acquiring intermediate metabolic phenotypes. Here, we assessed long-term proliferation, energy metabolism, and central carbon metabolism in human hepatoma HepG2 cells depleted in macroH2A1. MacroH2A1-depleted HepG2 cells were insensitive to serum exhaustion and showed two distinct, but interdependent changes in glucose and lipid metabolism in CSCs: (1) massive upregulation of acetyl-coA that is transformed into enhanced lipid content and (2) increased activation of the pentose phosphate pathway, diverting glycolytic intermediates to provide precursors for nucleotide synthesis. Integration of metabolomic analyses with RNA-Seq data revealed a critical role for the Liver X Receptor pathway, whose inhibition resulted in attenuated CSCs-like features. These findings shed light on the metabolic phenotype of epigenetically modified CSC-like hepatic cells, and highlight a potential approach for selective therapeutic targeting.

KW - cancer stem cells

KW - hepatocellular carcinoma

KW - Histone variants

UR - http://www.scopus.com/inward/record.url?scp=85054097059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054097059&partnerID=8YFLogxK

U2 - 10.1080/15592294.2018.1514239

DO - 10.1080/15592294.2018.1514239

M3 - Article

C2 - 30165787

AN - SCOPUS:85054097059

VL - 13

SP - 829

EP - 845

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 8

ER -